Enoxaparin in unstable angina patients with renal failure.

  title={Enoxaparin in unstable angina patients with renal failure.},
  author={Jean Philippe Collet and Gilles Montalescot and R{\'e}mi Choussat and L. C. Fern{\'a}ndez Lis{\'o}n and Annick Ankri},
  journal={International journal of cardiology},
  volume={80 1},
The dosage of the subcutaneous low molecular weight heparin enoxaparin in unstable angina patients undergoing coronary angiogram and coronary angioplasty depends clearly on the renal function. It should be significantly reduced to 64% of the standard dose (1 mg/kg per 12 h) in patients with severe renal failure (creatinine clearance<30 ml/min) to provide a safe anticoagulant profile. 


Publications citing this paper.
Showing 1-10 of 15 extracted citations

Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials.

Journal of the American College of Cardiology • 2003
View 5 Excerpts
Highly Influenced

Dosing of enoxaparin in renal impairment

P & T : a peer-reviewed journal for formulary management • 2017